Abbott next-gen FreeStyle Libre Continuous Glucose Monitor CE Mark’d

Abbott (ABT +0.8%) announces that its next-generation FreeStyle Libre 2 continuous glucose monitoring (CGM) system is now CE Mark certified. The device includes alarms to alert the user when blood sugar levels are out of range and an alarm if the sensor loses communication with the reader.

Market rollout will commence in the coming weeks.

Competitors DexCom (DXCM -5.1%) and Tandem Diabetes Care (TNDM-5.5%) were down on the news.

https://seekingalpha.com/news/3394129-abbotts-next-gen-freestyle-libre-cgm-ce-markd